H. Makimoto

发表

Association of Disease Stage and Response with Survival Following FP+RT Chemoradiotherapy for Esophageal Squamous Cell Carcinoma in Japanese Patients

M. Hirai, A. Kuwahara, T. Sakaeda, 2008 .

Circadian Variability of Pharmacokinetics of 5-Fluorouracil and CLOCK T3111C Genetic Polymorphism in Patients With Esophageal Carcinoma

M. Kasuga, N. Aoyama, T. Sakaeda, 2005, Therapeutic drug monitoring.

Development of a detection algorithm for statin‐induced myopathy using electronic medical records

M. Hirai, M. Tohkin, K. Sai, 2013, Journal of clinical pharmacy and therapeutics.

Associat ion of Toxicity of Sorafenib and Sunit inib for Human Kerat inocytes with Inhibit ion of Signal Transduct ion and Act ivator

M. Hirai, T. Bito, C. Nishigori, 2018 .

Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy

Y. Tsutsumi, T. Mayumi, H. Saito, 1999, British Journal of Cancer.

Identification of tumor vascular antigens by monoclonal antibodies prepared from rat‐tumor‐derived endothelial cells

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 1998, International journal of cancer.

Different Reactions of Aortic and Venular Endothelial Cell Monolayers to Histamine on Macromolecular Permeability: Role of cAMP, Cytosolic Ca2+ and F-actin

S. Nakagawa, T. Mayumi, K. Ikeda, 1999, Inflammation.

Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen.

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 1996, British Journal of Cancer.

Effective Cancer Targeting Using an Anti‐tumor Tissue Vascular Endotheliumspecific Monoclonal Antibody (TES‐23)

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 2000, Japanese journal of cancer research : Gann.

Tumor vascular targeting using a tumor-tissue endothelium-specific monoclonal antibody as an effective strategy for cancer chemotherapy.

Y. Tsutsumi, T. Mayumi, S. Nakagawa, 1999, Biochemical and biophysical research communications.

Bruceine B, A Potent Inhibitor of Leukocyte-Endothelial Cell Adhesion

S. Nakagawa, T. Mayumi, Motomasa Kobayashi, 1997, Inflammation.

Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.

M. Hirai, I. Yano, H. Minami, 2017, The Kobe journal of medical sciences.

Usefulness of the Prescription Checking System Associated with Laboratory Data in the Prescription Queries

I. Yano, Kazuhiko Yamashita, H. Makimoto, 2019, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).

Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation.

S. Markova, T. Sakaeda, K. Okumura, 2006, Drug metabolism and pharmacokinetics.

Apoptotic Effects of the Extracts of Cordyceps militaris via Erk Phosphorylation in a Renal Cell Carcinoma Cell Line

M. Hirai, A. Uda, Kazuhiko Yamashita, 2015, Phytotherapy research : PTR.

Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition

M. Hirai, T. Bito, C. Nishigori, 2013, Journal of experimental & clinical cancer research : CR.

Effects of Ascorbyl-2-phosphate Magnesium on Human Keratinocyte Toxicity and Pathological Changes by Sorafenib.

M. Hirai, T. Bito, I. Yano, 2017, Biological & pharmaceutical bulletin.

Isolation and Properties of Tumor‐derived Endothelial Cells from Rat KMT‐17 Fibrosarcoma

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 1995, Japanese journal of cancer research : Gann.

Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients

K. Harada, H. Miyake, M. Hirai, 2016, Targeted Oncology.

Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats.

Y. Tsutsumi, T. Mayumi, S. Nakagawa, 1997, Biochemical and biophysical research communications.

Pharmaceutical Intervention to Manage Polypharmacy in Elderly Patients based on STOPP Criteria

M. Hirai, Y. Akazawa, A. Uda, 2016 .

Kobe University Repository : Kernel タイトル Tit le Everolimus-induced human kerat inocytes toxicity is mediated by STAT 3 inhibit ion 著者

M. Hirai, T. Bito, C. Nishigori, 2017 .

Association of Toxicity of Sorafenib and Sunitinib for Human Keratinocytes with Inhibition of Signal Transduction and Activator of Transcription 3 (STAT3)

M. Hirai, T. Bito, C. Nishigori, 2014, PloS one.

Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot Skin Reaction: A Single-Arm, Open-Label Phase I/II Study (DGA Study)

K. Harada, M. Fujisawa, I. Yano, 2022, The oncologist.

STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population

K. Harada, H. Miyake, M. Hirai, 2016, Medical Oncology.

Evaluation of Team-based Learning as a Teaching Method for Pharmacist Education

I. Yano, A. Uda, Takeshi Kimura, 2018 .

Potentially inappropriate medications in elderly Japanese patients: effects of pharmacists’ assessment and intervention based on Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions criteria ver.2

I. Yano, A. Uda, H. Makimoto, 2017, Journal of clinical pharmacy and therapeutics.

Evaluation of the Collaboration System between Community Pharmacies and Hospital for the Management of Oral Anti-cancer Therapy Using Information Sharing Tools and Team-based Learning

I. Yano, Takahiro Ito, H. Makimoto, 2020, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).

β2-Adrenergic Receptor Genotype-Related Changes in cAMP Levels in Peripheral Blood Mononuclear Cells After Multiple-Dose Oral Procaterol

T. Sakaeda, K. Nishiguchi, F. Komada, 2001, Pharmaceutical Research.

IL-1beta genotype-related effect of prednisolone on IL-1beta production in human peripheral blood mononuclear cells under acute inflammation.

S. Markova, A. Kuwahara, T. Sakaeda, 2007, Biological & pharmaceutical bulletin.

Assessment of Pharmacist's Intervention in the Prescription Process in Pharmaceutical Outpatient Clinics

M. Hirai, I. Yano, Masayoshi Hashimoto, 2017 .